4-methoxyamphetamine has been researched along with rosiglitazone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drzewoski, J; Grzeszczak, W | 1 |
| Schatz, DA; Shuster, JJ | 1 |
| Kollar, C; Waksman, J | 1 |
3 other study(ies) available for 4-methoxyamphetamine and rosiglitazone
| Article | Year |
|---|---|
[Rosiglitazone--under fire].
Topics: Clinical Trials as Topic; Death; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Myocardial Infarction; Rosiglitazone; Thiazolidinediones | 2007 |
The rosigliazone meta-analysis: lessons for the future.
Topics: Death; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Ischemia; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2008 |
Comments on 'Rebuttal to Carpenter et al.' Comments on 'Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death' by J. J. Shuster, L. S. Jones and D. A. Salmon, Statistics in Medicin
Topics: Death; Humans; Hypoglycemic Agents; Meta-Analysis as Topic; Myocardial Infarction; Rosiglitazone; Thiazolidinediones | 2009 |